Despite some positive results from clinical trials for COVID-19 treatments, separate tests of the same therapies have not met primary endpoints.
List view / Grid view
Filter the results
The developers of Avigan have increased production and announced a Phase III clinical trial testing its efficacy against COVID-19.
Whitepaper: pAVEwayTM – microbial expression system for the efficient large scale production of therapeutic proteins
pAVEway™ is an innovative expression system in E. coli that enables rapid creation of novel recombinant strains and the development of downstream processes that ensure industry leading product titres and efficient scale-up of the production of proteins of therapeutic utility...
Fujifilm Diosynth Biotechnologies has announced the successful completion of its 100th program using its pAVEway™ Advanced Protein Expression system...
19 June 2017 | By
Fujifilm first penetrated into overseas markets primarily through its Imaging Solutions business. The company established a German subsidiary in charge of the comprehensive management of its European operations in 1966 and a manufacturing company in the Netherlands which was tasked with manufacturing color paper and color films in 1982. Today,…